Statistics

Total Visits

Views
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial56

Select a period of time:

Number of views in the range

Views
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial16

Views

Views
December 20250
January 20260
February 20260
March 20261
April 20265
May 20263
June 20267
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Netherlands2
Angola1
Canada1
France1
Mexico1
Senegal1
 

Top cities views

Views
Groningen2
Dakar1
Grenoble1
Los Angeles1
Miami1
Montreal1
Querétaro1